PMID- 31464358 OWN - NLM STAT- MEDLINE DCOM- 20200127 LR - 20200127 IS - 1365-2672 (Electronic) IS - 1364-5072 (Linking) VI - 127 IP - 6 DP - 2019 Dec TI - A phenotypic screening bioassay for Escherichia coli stress and antibiotic responses based on Fourier-transform infrared (FTIR) spectroscopy and multivariate analysis. PG - 1776-1789 LID - 10.1111/jam.14429 [doi] AB - AIMS: To develop and optimize a Fourier-transform infrared spectroscopy (FTIRS) phenotypic screening bioassay for stress responses, regarding the effect of nutrient content, bacterial growth phase and stress agent exposure time. METHODS AND RESULTS: A high-throughput FTIRS bioassay was developed to distinguish the stress responses of Escherichia coli to sodium hydroxide, hydrochloric acid, sodium chloride, sodium hypochlorite and ethanol. Principal component analysis and hierarchical clustering were used to quantify the effect of each parameter on bioassay performance, namely its reproducibility and metabolic resolution. Bioassay performance varied greatly, ranging from poor to very good. Spectra were partitioned into biologically relevant regions to evaluate their contributions to bioassay performance, but further improvements were not observed. Bioassay optimization was validated against empirical parameters, which confirmed a closer representation of known mechanisms on the antibiotic-induced stress responses. CONCLUSIONS: The optimized bioassay used standard nutrient content, cells in the late-stationary growth phase and a one-shift exposure duration. Only the optimized bioassay adequately and reproducibly distinguished the E. coli stress and antibiotic responses. The absence of performance improvements using partitioned spectra indicated that stress responses are imprinted on the whole-spectra metabolic signature. SIGNIFICANCE AND IMPACT OF THE STUDY: Highly optimized FTIRS bioassay parameters are vital in capturing whole-spectra metabolic signatures that can be used for satisfactory and reproducible phenotypic screening of stress and antibiotic responses. CI - (c) 2019 The Society for Applied Microbiology. FAU - Ribeiro da Cunha, B AU - Ribeiro da Cunha B AUID- ORCID: 0000-0002-0303-9416 AD - iBB - Institute of Bioengineering and Biosciences (iBB), Instituto Superior Tecnico (IST), Universidade de Lisboa, Lisboa, Portugal. AD - ISEL - Instituto Superior de Engenharia de Lisboa (ISEL), Instituto Politecnico de Lisboa (IPL), Lisboa, Portugal. FAU - Fonseca, L P AU - Fonseca LP AD - iBB - Institute of Bioengineering and Biosciences (iBB), Instituto Superior Tecnico (IST), Universidade de Lisboa, Lisboa, Portugal. FAU - Calado, C R C AU - Calado CRC AD - ISEL - Instituto Superior de Engenharia de Lisboa (ISEL), Instituto Politecnico de Lisboa (IPL), Lisboa, Portugal. LA - eng GR - IDI&CA/IPL/2017/DrugsPlatf/ISEL/Instituto Politecnico de Lisboa/ GR - IDI&CA/IPL/2018/RenalProg/ISEL/Instituto Politecnico de Lisboa/ PT - Journal Article DEP - 20191008 PL - England TA - J Appl Microbiol JT - Journal of applied microbiology JID - 9706280 RN - 0 (Anti-Bacterial Agents) SB - IM MH - Anti-Bacterial Agents/*pharmacology MH - Bacteriological Techniques/*methods MH - Escherichia coli/*drug effects MH - High-Throughput Screening Assays MH - *Multivariate Analysis MH - Phenotype MH - Reproducibility of Results MH - *Spectroscopy, Fourier Transform Infrared MH - Stress, Physiological/*drug effects OTO - NOTNLM OT - Escherichia coli OT - Fourier-transform infrared spectroscopy OT - antibiotics OT - metabolism OT - optimization OT - stress response EDAT- 2019/08/30 06:00 MHDA- 2020/01/28 06:00 CRDT- 2019/08/30 06:00 PHST- 2019/02/14 00:00 [received] PHST- 2019/08/21 00:00 [revised] PHST- 2019/08/21 00:00 [accepted] PHST- 2019/08/30 06:00 [pubmed] PHST- 2020/01/28 06:00 [medline] PHST- 2019/08/30 06:00 [entrez] AID - 10.1111/jam.14429 [doi] PST - ppublish SO - J Appl Microbiol. 2019 Dec;127(6):1776-1789. doi: 10.1111/jam.14429. Epub 2019 Oct 8.